Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
HDAC
Research
A SMRT new target for male contraceptives works in mice
A drug with past life as a potential anti-cancer agent might someday have a new job as "the pill" for men, new data in mice suggest.
Helen Floersh
Feb 22, 2024 3:35pm
Homing in on one HDAC sees early success in a lung cancer
Mar 20, 2023 11:54am
Could inhibiting both HDAC and PD-1 improve I-O treatments?
Jun 24, 2019 10:30am
Viracta's combo garners high response in EBV-linked lymphoma
Jun 3, 2019 11:39am
Xynomic preps broad push for HDAC cancer drug
Jun 1, 2018 10:26am
Syndax pals up with Nektar on entinostat combo trial
May 31, 2018 10:10am